Background Triggering receptor expressed on myeloid cells-1 (TREM-1) has emerged as an
important inflammatory marker of immune response associated with severity and mortality …

Uncontrolled inflammatory responses play a critical role in coronavirus disease (COVID-19).
In this context, because the triggering-receptor expressed on myeloid cells-1 (TREM-1) is …

Despite of the ongoing vaccination against Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection, the high transmissibility and severity of coronavirus …

Abstract Background The immuno-receptor Triggering Expressed on Myeloid cells-1 (TREM-
1) is activated during bacterial infectious diseases, where it amplifies the inflammatory …

Objective The inflammatory/anti‐inflammatory balance has an important role in the clinical
course of SARS‐CoV‐2 infection (COVID‐19), which has affected over 100 million people …

Background The uncontrolled inflammatory response plays a critical role in the novel
coronavirus disease (COVID-19) and triggering receptor expressed on myeloid cells-1 …

Background Delayed diagnosis and inadequate treatment caused by limited biomarkers are
associated with the outcomes of COVID-19 patients. It is necessary to identify other …

Patients with sepsis display increased concentrations of sTREM-1 (soluble Triggering
Receptor Expressed on Myeloid cells 1), and a phase II clinical trial focusing on TREM-1 …

Limited understanding of T cell responses against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has impeded vaccine development and drug discovery for …

Background Research on biomarkers associated with the severity and adverse prognosis of
COVID-19 can be beneficial for improving patient outcomes. However, there is limited …